Table 1.
Baseline characteristics of study participants by level of healthcare facility.
Fig 1.
Patient flow chart.
Table 2.
Characetristics of patients who were successfully traced versus those who were not.
Fig 2.
Kaplan Meir curves showing cumulative incidence of mortality among patients who did and did not experience pretreatment LFU Fig 2a) overall Fig 2b) stratified by sex Fig 2c) stratified by HIV status and Fig 2d) stratified by health facility level.
Table 3.
Hazard ratios of mortality comparing patients initiated on TB treatment with those who experienced pretreatment loss to follow-up overall and stratified by HIV status.
Fig 3.
Uncorrected and corrected TB mortality estimate at health facility level 6 months after TB diagnosis.
Uncorrected indicates cumulative mortality rate among persons started on TB treatment, corrected indicates cumulative mortality updated using vital status of patients successfully traced.